BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22682188)

  • 21. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.
    He L; Ma J; Mei X; Lu S; Li X; Xi L
    Mycoses; 2018 Apr; 61(4):231-236. PubMed ID: 29178398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chromoblastomycosis with terbinafine: experience with four cases.
    Bonifaz A; Saúl A; Paredes-Solis V; Araiza J; Fierro-Arias L
    J Dermatolog Treat; 2005 Feb; 16(1):47-51. PubMed ID: 15897168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical improvement of chromoblastomycosis refractory to itraconazole successfully treated with high dose of terbinafine.
    Silva-Rocha WP; Cardoso FJ; Colalto W; Melo AS; Chaves GM
    J Dermatol; 2013 Sep; 40(9):775-6. PubMed ID: 23865635
    [No Abstract]   [Full Text] [Related]  

  • 26. First reported Australian case of Cladophilophora arxii: features consistent with possible primary pulmonary chromoblastomycosis.
    Brischetto A; Kidd S; Baird R
    Am J Trop Med Hyg; 2015 Apr; 92(4):791-3. PubMed ID: 25624408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
    Khan S; Kumar A; Vinod V; Prabhakar V; Eapen M; Thomas J; Dinesh K; Karim S
    J Infect Dev Ctries; 2015 Mar; 9(3):325-9. PubMed ID: 25771474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verrucous plaques on the arm.
    Smith LC; Fisher KR; Granese J; Baselski V; Rasberry RD; Skinner R
    Arch Dermatol; 2009 Feb; 145(2):195-200. PubMed ID: 19221272
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case Report: Successful Treatment of Chromoblastomycosis Caused by
    Bao F; Wang Q; Yu C; Shang P; Sun L; Zhou G; Wu M; Zhang F
    Am J Trop Med Hyg; 2018 Jul; 99(1):124-126. PubMed ID: 29785921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
    Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM; Ramos-Caro FA
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J; Li R; Zhang M; Liu L; Wan Z
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
    Pradeepkumar NS; Joseph NM
    J Infect Dev Ctries; 2011 Jul; 5(7):556-60. PubMed ID: 21795827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromoblastomycosis in Kerala, India.
    Chandran V; Sadanandan SM; Sobhanakumari K
    Indian J Dermatol Venereol Leprol; 2012; 78(6):728-33. PubMed ID: 23075642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromoblastomycosis presenting as a phagedenic ulcer on the face.
    Naveen KN; Shetty PC; Naik AS; Pai VV; Hanumanthayya K; Udupishastry D
    Int J Dermatol; 2012 May; 51(5):576-8. PubMed ID: 21923692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.